ANIX RSI Chart
Last 7 days
1.7%
Last 30 days
-7.9%
Last 90 days
-27.9%
Trailing 12 Months
-14.9%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 436.5K | 361.0K | 285.5K | 210.0K |
2021 | 763.0K | 513.0K | 513.0K | 512.0K |
2019 | 0 | 1.4M | 612.5K | 250.0K |
2018 | 0 | 918.8K | 1.5M | 1.1M |
2017 | 0 | 0 | 331.3K | 362.5K |
2016 | 0 | 0 | 4.8M | 300.0K |
2015 | 0 | 0 | 0 | 9.3M |
2014 | 0 | 0 | 0 | 0 |
2013 | 0 | 0 | 0 | 388.9K |
2012 | 1.4M | 1.6M | 1.4M | 940.0K |
2011 | 798.8K | 866.9K | 935.1K | 1.0M |
2010 | 0 | 0 | 0 | 730.7K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 30, 2024 | catelani michael | acquired | 2,996 | 2.52 | 1,189 | president, coo, & cfo |
Apr 09, 2024 | titterton lewis h jr | bought | 49,229 | 3.28 | 15,009 | - |
Mar 15, 2024 | baskies arnold m | bought | 36,300 | 3.63 | 10,000 | - |
Mar 15, 2024 | kumar amit | bought | 96,600 | 3.22 | 30,000 | chief executive officer |
Oct 31, 2023 | catelani michael | acquired | 3,004 | 2.69 | 1,117 | president, coo & cfo |
Oct 10, 2023 | titterton lewis h jr | acquired | 41,200 | 2.575 | 16,000 | - |
Jul 31, 2023 | kumar amit | sold | -42,126 | 3.57 | -11,800 | chief executive officer |
Jul 28, 2023 | kumar amit | acquired | 103,000 | 2.575 | 40,000 | chief executive officer |
Jul 28, 2023 | kumar amit | sold (taxes) | -103,001 | 3.63 | -28,375 | chief executive officer |
Jul 27, 2023 | titterton lewis h jr | acquired | 309,000 | 2.575 | 120,000 | - |
Which funds bought or sold ANIX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | Royal Bank of Canada | reduced | -13.27 | -2,000 | 3,000 | -% |
May 15, 2024 | STATE STREET CORP | unchanged | - | -82,460 | 338,520 | -% |
May 15, 2024 | MORGAN STANLEY | added | 1.82 | -25,652 | 115,864 | -% |
May 15, 2024 | Laird Norton Wetherby Trust Company, LLC | added | 63.82 | 454,133 | 1,885,210 | 0.26% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | added | 591 | 299,146 | 364,772 | -% |
May 15, 2024 | Tyler-Stone Wealth Management | unchanged | - | -15,966 | 65,545 | 0.03% |
May 15, 2024 | OCCUDO QUANTITATIVE STRATEGIES LP | new | - | 57,888 | 57,888 | 0.01% |
May 15, 2024 | Squarepoint Ops LLC | new | - | 49,599 | 49,599 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 104 | 6,781 | 17,269 | -% |
May 15, 2024 | MARSHALL WACE, LLP | added | 147 | 40,862 | 82,280 | -% |
Unveiling Anixa Biosciences Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Anixa Biosciences Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.52 | 7.43 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 19.1B | 2.0B | -57.61 | 9.55 | ||||
BMRN | 14.6B | 2.5B | 71.11 | 5.91 | ||||
INCY | 12.8B | 3.8B | 17.13 | 3.39 | ||||
MID-CAP | ||||||||
BBIO | 5.8B | 107.9M | -10.63 | 48.09 | ||||
APLS | 5.1B | 524.1M | -12.22 | 9.73 | ||||
AXSM | 3.7B | 251.0M | -12.4 | 14.64 | ||||
ARWR | 3.1B | 240.7M | -6.6 | 12.77 | ||||
ACAD | 2.5B | 813.8M | -1.4K | 3.01 | ||||
SMALL-CAP | ||||||||
NVAX | 2.0B | 996.6M | -5.07 | 2.03 | ||||
CPRX | 1.9B | 411.3M | 29.69 | 4.7 | ||||
CRBP | 489.5M | 881.7K | -14.5 | 481.06 | ||||
INO | 330.9M | 4.9M | -2.65 | 67.99 | ||||
IBIO | 15.7M | 2.1M | -0.68 | 7.61 |
Anixa Biosciences Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2018Q4 | 2018Q3 | 2018Q2 | 2017Q4 | 2017Q3 | 2016Q4 | 2016Q3 | 2015Q4 | 2015Q3 |
Revenue | - | - | - | - | 210,000 | 140,000 | 70,000 | - | - | 513,000 | - | - | 250,000 | - | 362,500 | 750,000 | - | 362,500 | 326,667 | 290,833 | 255,000 | 140,000 |
Costs and Expenses | 18.3% | 3,609,000 | 3,051,000 | 2,844,000 | 2,770,000 | 2,556,000 | 4,076,500 | 4,388,000 | 2,437,000 | 2,746,000 | 2,128,631 | 2,184,412 | 2,843,234 | 5,407,714 | 5,968,304 | 2,150,954 | - | - | - | - | - | - |
S&GA Expenses | 57.4% | 2,260,000 | 1,436,000 | 1,756,000 | 1,611,000 | 1,488,000 | 1,903,500 | 2,221,000 | 1,415,000 | 1,533,000 | 1,257,443 | 1,056,963 | 1,281,966 | 2,309,275 | 2,703,752 | 908,767 | - | - | - | - | - | - |
R&D Expenses | -16.5% | 1,349,000 | 1,615,000 | 1,088,000 | 998,000 | 1,068,000 | 2,173,000 | 2,167,000 | 1,022,000 | 828,000 | 871,188 | 1,085,574 | 1,269,393 | 2,432,906 | 2,942,071 | 660,193 | - | - | - | - | - | - |
EBITDA Margin | 0% | -45.19 | -45.19 | -35.10 | -28.69 | -24.26 | -18.58 | -18.54 | -18.53 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | - | - | - | - | - | - | 325 | 277 | 264 | 1,134 | 1,946 | 18,364 | - | - | - | - | 57,762 | 71,667 | 136,708 | 132,357 | 118,127 | 115,981 |
Earnings Before Taxes | - | - | - | - | - | - | - | - | - | - | -2,111,061 | -2,166,048 | -2,574,934 | -5,391,520 | -5,593,576 | -1,392,514 | -1,785,820 | -1,794,400 | -1,047,670 | -1,103,775 | -1,292,413 | -1,602,179 |
EBT Margin | 0% | -45.48 | -45.48 | -35.32 | -28.87 | -24.42 | -18.66 | -18.62 | -18.62 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -21.0% | -3,255,000 | -2,690,000 | -2,511,000 | -2,288,000 | -2,322,000 | -4,013,000 | -4,334,000 | -2,399,000 | -2,208,000 | -2,026,488 | -2,140,028 | -2,574,934 | -5,391,520 | -5,593,576 | -1,392,514 | - | - | - | - | - | - |
Net Income Margin | -9.5% | -51.16 | -46.72 | -39.19 | -32.74 | -30.90 | -25.30 | -21.76 | -18.31 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | -17.3% | -2,309,000 | -1,969,000 | -1,445,000 | -807,000 | -1,988,000 | -1,045,000 | -1,481,000 | -1,242,000 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -0.6% | 25.00 | 26.00 | 27.00 | 28.00 | 28.00 | 30.00 | 33.00 | 33.00 | 35.00 | 36.00 | 37.00 | 38.00 | 15.00 | 9.00 | 9.00 | 6.00 | 9.00 | 6.00 | 7.00 | 8.00 | 6.00 |
Current Assets | -0.5% | 25.00 | 25.00 | 26.00 | 27.00 | 28.00 | 30.00 | 32.00 | 33.00 | 35.00 | 36.00 | 37.00 | 38.00 | 15.00 | 9.00 | 9.00 | 6.00 | 6.00 | 6.00 | 7.00 | 7.00 | 6.00 |
Cash Equivalents | 9.1% | 1.00 | 1.00 | 3.00 | 6.00 | 10.00 | 12.00 | 24.00 | 28.00 | 30.00 | 29.00 | 27.00 | 28.00 | 12.00 | 6.00 | 6.00 | 3.00 | 3.00 | 3.00 | 4.00 | 4.00 | 4.00 |
Net PPE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Liabilities | -17.8% | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 2.00 | 2.00 | 1.00 | 2.00 | 1.00 | - | - | - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | - | - | - |
Current Liabilities | -18.1% | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 2.00 | 1.00 | 1.00 | 2.00 | 1.00 | 1.00 | 1.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 1.00 |
Shareholder's Equity | 1.1% | 25.00 | 24.00 | 26.00 | 26.00 | 27.00 | 28.00 | 31.00 | 31.00 | 33.00 | 35.00 | 36.00 | 37.00 | 13.00 | 8.00 | 8.00 | 5.00 | 5.00 | 5.00 | 5.00 | 6.00 | 5.00 |
Retained Earnings | -1.4% | -231 | -228 | -225 | -222 | -220 | -218 | -214 | -212 | -208 | -204 | -200 | -196 | -194 | -191 | -189 | -187 | -184 | -181 | -179 | -177 | -175 |
Additional Paid-In Capital | 1.4% | 256 | 252 | 251 | 249 | 248 | 247 | 246 | 244 | 242 | 240 | 237 | 234 | 207 | 200 | 198 | 192 | 190 | 187 | 185 | 184 | 180 |
Accumulated Depreciation | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Shares Outstanding | 2.0% | 32.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 30.00 | 30.00 | 30.00 | 30.00 | 31.00 | - | - | - | - | - | - | - | - | - |
Minority Interest | -3.6% | -1.00 | -0.97 | -0.93 | -0.90 | -0.88 | -0.85 | -0.79 | -0.76 | -0.72 | -0.67 | -0.61 | -0.56 | -0.52 | -0.50 | -0.48 | -0.46 | -0.45 | -0.42 | -0.40 | -0.37 | -0.34 |
Float | - | - | - | - | 121 | - | - | - | 93.00 | - | - | - | 140 | - | - | - | 35.00 | - | - | - | 72.00 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -17.3% | -2,309 | -1,969 | -1,445 | -807 | -1,988 | -1,593 | -1,396 | -2,306 | -1,197 | -1,045 | -1,481 | -1,242 | -1,170 | -1,414 | -1,290 | -1,556 | -1,914 | -1,337 | -640 | -1,434 | -1,329 |
Share Based Compensation | -4.2% | 1,108 | 1,157 | 1,153 | 1,155 | 957 | 1,072 | 1,330 | 1,463 | 2,135 | 2,699 | 3,048 | 881 | 875 | - | - | -1,110 | 1,021 | -9,294 | 831 | -1,321 | 2,750 |
Cashflow From Investing | 121.8% | 129 | -593 | -980 | -3,444 | -585 | -9,917 | -2,911 | 250 | 1,850 | 2,807 | 1,000 | -8,399 | 675 | 500 | -520 | 250 | -535 | -250 | 650 | -1,175 | 250 |
Cashflow From Financing | 711.1% | 2,263 | 279 | 3.00 | 81.00 | 3.00 | -384 | 829 | - | - | 144 | - | 25,361 | 6,061 | 1,403 | 4,851 | 1,373 | 1,780 | 682 | 565 | 2,280 | 2,176 |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Jan. 31, 2024 | Jan. 31, 2023 | |
Income Statement [Abstract] | ||
Revenue | ||
Operating costs and expenses: | ||
Research and development expenses (including non-cash share-based compensation expenses of $489 and $505, respectively) | 1,349 | 1,068 |
General and administrative expenses (including non-cash share-based compensation expenses of $771 and $558, respectively) | 2,260 | 1,488 |
Total operating costs and expenses | 3,609 | 2,556 |
Loss from operations | (3,609) | (2,556) |
Interest income | 319 | 202 |
Net loss | (3,290) | (2,354) |
Less: Net loss attributable to noncontrolling interest | (35) | (32) |
Net loss attributable to common shareholders | $ (3,255) | $ (2,322) |
Net loss per common share attributable to common shareholders: | ||
Basic | $ 0.10 | $ 0.08 |
Diluted | $ 0.10 | $ 0.08 |
Weighted average common shares outstanding: | ||
Basic | 31,446 | 30,921 |
Diluted | 31,446 | 30,921 |
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Jan. 31, 2024 | Oct. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 998 | $ 915 |
Short-term investments | 22,800 | 22,929 |
Receivables | 391 | 270 |
Prepaid expenses and other current assets | 1,030 | 1,242 |
Total current assets | 25,219 | 25,356 |
Operating lease right-of-use asset | 153 | 166 |
Total assets | 25,372 | 25,522 |
Current liabilities: | ||
Accounts payable | 364 | 206 |
Accrued expenses | 1,242 | 1,770 |
Operating lease liability | 54 | 52 |
Total current liabilities | 1,660 | 2,028 |
Operating lease liability, non-current | 108 | 123 |
Total liabilities | 1,768 | 2,151 |
Commitments and contingencies (Note 10) | ||
Equity: | ||
Preferred stock, value | ||
Common stock, par value $.01 per share; 100,000,000 shares authorized; 31,754,375 and 31,145,219 shares issued and outstanding as of January 31, 2024 and October 31, 2023, respectively | 318 | 311 |
Additional paid-in capital | 255,738 | 252,222 |
Accumulated deficit | (231,451) | (228,196) |
Total shareholders’ equity | 24,605 | 24,337 |
Noncontrolling interest (Note 2) | (1,001) | (966) |
Total equity | 23,604 | 23,371 |
Total liabilities and equity | 25,372 | 25,522 |
Series A Convertible Preferred Stock [Member] | ||
Equity: | ||
Preferred stock, value |